1. Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate
   Natalia Pieńkowska et al, 2021, International Journal of Molecular Sciences CrossRef
2. Addressing artifacts of colorimetric anticancer assays for plant-based drug development
   Salma Batool et al, 2022, Medical Oncology CrossRef
3. Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in Vivo
   Wei Li et al, 2017, Journal of Agricultural and Food Chemistry CrossRef
4. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
   Mao-Bin Meng et al, 2016, Oncotarget CrossRef
5. Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity
   Yuri Ishiguro et al, 2018, International Journal of Pharmaceutics CrossRef
6. Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
   Huimei Huang et al, 2021, Frontiers in Immunology CrossRef
7. RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide
   Bin Lu et al, 2018, Cancer Letters CrossRef
8. The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment
   Je Lin Sieow et al, 2018, Frontiers in Cell and Developmental Biology CrossRef
9. Targeting Cancer Metabolism and Current Anti-Cancer Drugs
   Witchuda Sukjoi et al, 2021, Reviews on New Drug Targets in Age-Related Disorders CrossRef
10. Targeting Energy Metabolism in Cancer Treatment
    Joanna Kubik et al, 2022, International Journal of Molecular Sciences CrossRef
11. The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view
    Salah Mohamed El Sayed et al, 2017, Medical Hypotheses CrossRef
12. The Contribution of Necroptosis in Neurodegenerative Diseases
    Lifei Shao et al, 2017, Neurochemical Research CrossRef
13. Glucose metabolic reprogramming and modulation in glycerol biosynthesis regulates drug resistance in clinical isolates of Candida
    Sajad Ahmad Padder et al, 2023, Journal of Applied Microbiology CrossRef
14. Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial–mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis
    Yoon-Jin Lee et al, 2019, Archives of Pharmacal Research CrossRef
15. 3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2
    Zhou Can et al, 2017, Anti-Cancer Drugs CrossRef
16. 3-Bromopyruvate inhibits the malignant phenotype of malignantly transformed macrophages and dendritic cells induced by glioma stem cells in the glioma microenvironment via miR-449a/MCT1
    Yujing Sheng et al, 2020, Biomedicine & Pharmacotherapy CrossRef
17. Topical 3-bromopyruvate is a novel targeted therapy for melanoma in a preclinical model
    Masayuki Yamada et al, 2018, Journal of Dermatological Science CrossRef
18. Apoptosis and necroptosis-inducing effects of arctigenin on nasal septum carcinoma RPMI-2650 cells in 2D and 3D culture
    Yoon-Jin Lee et al, 2020, Molecular & Cellular Toxicology CrossRef
19. Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer
    Hsin-Chih Yeh et al, 2022, European Journal of Pharmacology CrossRef
20. Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2+/− Mice
    Ashley T. Jones et al, 2019, Neoplasia CrossRef
21. A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells
    Thomas C. Chen et al, 2017, Cancer Letters CrossRef